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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effects and costs of primary, secondary and tertiary strategies to prevent oral disease in dependent older people.
B A C K G R O U N D
Description of the condition
The number of older people, defined as those above sixty-five years
of age, is projected to increase exponentially from an estimated 524
million in 2010, to nearly 1.5 billion in 2050 worldwide (WHO
2011). Demographic and family changes mean that as people age
further and lose their independence (defined as a reduction in their
ability to perform activities of daily living) (Kingston 2012), fewer
will have families to care for them and an increasing number will
either be cared for at home or will enter formal care (WHO 2008;
Branca 2009; Belsi 2013).
The cost of treating oral disease is expected to rise and a significant
proportion of this cost in the future will relate to the provision of
treatment for dependent older people (FDI 2016). For example, in
the European Union, this cost is projected to rise from EURO54
billion in 2000 to EURO93 billion in 2020, greater than the
costs of treating stroke and dementia combined (Widstrom 2004).
Compared to two decades ago, many older people will keep their
teeth for their lifetime (Samson 2008; Steele 2009; Hopcraft
2012; Thomson 2014). Since many in this population were not
exposed to fluoride at an early age, dental decay in this population
is now a major public health issue (Thomson 2014; Karki 2015;
Morgan 2015). Moreover, restorations (’fillings’) have a limited
lifespan. Gumdisease disproportionately affects older adults and is
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becoming an increasing problem around dental implants, leading
to implant failure (Derks 2015).
Self-care deteriorates with increasing age, dry mouth increases due
to poly-pharmacy and diets also become rich in sugars, further in-
creasing the risk of future disease.Overall, poor oral health impacts
on older people’s quality of life, their self-esteem, general health
and diet (Nowjack-Raymer 2003; Walls 2004; Moynihan 2007;
Gerritsen 2010; Thomson 2014; Porter 2015). In dentate older
people, a number of oral diseases have risk factors such as smok-
ing, age, and poor glycaemic control, that are in common with
systemic diseases. There is also a growing interest in the possibility
of a bi-directional relationship between oral health and cardio-
vascular disease, across a shared inflammatory-mediating pathway
(Ford 2010). Diet plays a key role in disease prevention in older
age, as poor diet has been linked to illnesses such as osteoporosis,
atherosclerosis and bowel disease (Touger-Decker 2007). Equally,
there is evidence that good oral health has very positive effects on
the nutritional intake of older adults (Moynihan 2007). Evidence
suggests that poor oral health can impact significantly on older
patients’ quality of life and their ability to go about their daily
routines (Nitschke 2004; Steele 2004). Large sets of longitudinal
epidemiological data on ageing have shown that a deterioration
in oral health and oral health-related quality of life increases the
risk of depressive symptoms among older adults, highlighting the
importance of oral health as a determinant of subjective well-being
in later life (Rouxel 2016).
Service provision for older people is often poor for those who
reside at home and in residential care (De Visschere 2006;
Gluhak 2010; Hopcraft 2012), given the challenge of the setting
(Bots-VantSpijker 2014; van der Putten 2014;Walls 2014). Access
to domiciliary services is difficult and admission to hospital for
dental problems is distressing and costly (Kandelman 2008; Pretty
2014a). The standard of knowledge about oral health amongst for-
mal and informal carers is poor (Paulsson 2002;Nitschke2005;De
Visschere 2015a; Brocklehurst 2015; Everaars 2015), and income-
related inequality in dental service utilisation, and oral health in-
equalities amongst older people are common (Listl 2010; Tsakos
2011; Thomson 2012). As older people’s independence deteri-
orates, all these factors are compounded further (WHO 2012;
Thomson 2014). This makes prevention paramount.
Description of the intervention
Primary prevention includes the provision of information to help
individuals make informed choices about their health-related be-
haviour and strategies to reduce the risk factors associated with
disease expression. Examples of primary prevention include care-
home initiated health promotion programmes by professional
staff, or targeted health promotion programmes for individuals
who are cared for at home by family or other informal carers.
Further examples include the application of topical high strength
fluoride, chlorhexidine and other health technologies, or tooth-
brushing programmes and toothpaste schemes.
Secondary prevention strategies include those that detect disease
early and intervene to prevent its progression. Examples of sec-
ondary prevention include the use of population-based or care-
home screening and early detection programmes undertaken by
members of the dental team or care-home staff.
Tertiary prevention strategies include those that reduce morbidity
by restoring function and reducing disease-related complications.
Examples of tertiary prevention include the use of domiciliary care
or mobile services to restore diseased teeth.
How the intervention might work
Primary prevention strategies like health education aim to im-
prove the knowledge and skill levels of people providing care for
older people (Heath 1999; Albrecht 2013; Pretty 2014b; Janssens
2016). Often designed as complex interventions, these types of
programmes commonly target carers (for those being cared for
at home) and care-home staff (Frenkel 2002; MacEntee 2007;
Janssens 2016). Fluoride is central to the primary prevention of
dental caries in older people (Murray 1991; Pretty 2014b). Flu-
oride can be delivered either locally or systemically, and reduces
the susceptibility of tooth enamel to demineralisation (Tan 2010;
Gibson 2011). In addition, it prevents disease progression by
promoting remineralisation of early caries lesions (Featherstone
1988). Systemic methods of delivery include water fluoridation,
whilst local methods of delivery, like fluoride varnish, are com-
monly provided by dental professionals (Maurinho 2013). Flu-
oride varnish is recommended for vulnerable groups (Maurinho
2013) and the use of high strength topical fluorides (greater than
5000 parts per million (ppm)) has recently been advocated for
dependent older people (Walls 2012; Pretty 2014b). Toothpaste
has both a systemic and topical effect. Alongside fluoride (Wong
2011), other active ingredients in toothpaste, such as triclosan,
have demonstrated an ability to inhibit bacterial growth and re-
duce inflammation (Riley 2013). The mechanical removal of den-
tal plaque by toothbrushing can also help prevent dental caries
and reduce gingival inflammation.
Screening is a secondary preventive strategy to detect early disease
(Wilson 1968) and so prevent its progression. Identifying older
adults before they begin to manifest dental problems is considered
to be an important strategy (De Visschere 2015b). The use of fluo-
ride is also an effective secondary preventive strategy to prevent the
progression of existing carious lesions, and has been recommended
for this population group (MacEntee 2000; Pretty 2014b).
The provision of domiciliary and mobile care is a tertiary preven-
tive strategy and can help reduce the impact of the disease burden
once it has been expressed (Jablonski 2009; Pretty 2014a). An ex-
ample of one such project is the Gerodent project being conducted
in Belgium.
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Why it is important to do this review
Most high-income countries that provide state-funded or sub-
sidised dental care allocate the vast majority of these public funds
to primary dental care, where dentists see patients in high-street
practices. Dental diseases are almost entirely preventable, but little
or no provision is being made for the prevention of oral disease
in older people as they become increasingly dependent. As Walls
argues “the physical and clinical changes that occur with ageing
require an altered pattern of care for older people which is adjusted
to their disease risk” (Walls 2014).
The standard of knowledge amongst formal and informal carers is
poor (Paulsson 2002; Nitschke 2005; Vanobbergen 2005; Wardh
2013; De Visschere 2015a) and there is considerable variation in
oral hygiene practices in long-term care institutions (Vanobbergen
2005). Service provision is also poor due to the barriers of de-
livering oral health care in remote settings (De Visschere 2006;
Bots-VantSpijker 2014; Pretty 2014a; Walls 2014) and there is a
need to develop a multi-disciplinary approach across dental and
non-dental professionals, given the impact that oral health has
on general health in this population (Coleman 2002; Andersson
2007; Bethel 2014). If these issues are not addressed, inequalities
in dental service utilisation and oral health are likely to deteriorate
(Listl 2010; Tsakos 2011; Thomson 2012).
The World Health Organisation has called for a paradigm shift
towards the concept of ageing and has developed a set of priorities
based on four strategic areas (WHO 2012):
• healthy ageing over the life-course to tackle non-
communicable diseases;
• the design of health and long-term care systems that is fit
for ageing populations;
• provision of supportive age-friendly environments;
• strengthening the research and the evidence base.
Recommendations regarding the oral care of dependent older peo-
ple have been advocated (FDI 2016; Platform for Better Oral
Health in Europe 2015) and preventive care pathways have been
suggested (Pretty 2014b; Walls 2014), but little is known about
the effectiveness, cost-effectiveness or acceptability of primary, sec-
ondary and tertiary prevention for interventions delivered at a
population level.
O B J E C T I V E S
To assess the effects and costs of primary, secondary and tertiary
strategies to prevent oral disease in dependent older people.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include studies of an experimental (randomised and non-
randomised) and observational design:
• randomised controlled trials (RCTs);
• cluster RCTs;
• non-randomised controlled trials (NRCTs);
• controlled before-after studies (CBAs) with at least two
intervention and two control sites;
• interrupted time series studies (ITSs) with a clearly defined
point in time when the intervention occurred and at least three
data points before and three after the intervention.
Randomised trials are often not available to address questions
about the effects of health system interventions and implementa-
tion strategies and as such, it is appropriate to include NRCTs,
CBAs and ITSs.
Types of participants
Individuals over sixty-five years of age who depend on others to
provide some or all of their own self-care. This includes peoplewith
no current disease and those with existing disease, residing in care
homes (residential and nursing) or those who reside at home. It is
anticipated that the types of participants included in this review
will be heterogenous. However, a number of subgroups may be
identified, such as those living with dementia. Where possible,
these will be subject to subgroup analysis.
We will exclude:
• studies of participants who are independent enough to
attend primary dental care services;
• studies of participants who are hospitalised.
Types of interventions
The focus of this review is on primary, secondary and tertiary
prevention interventions to improve the oral health of dependent
older people. The comparator will be no treatment or different
treatment (’head-to-head’).
Primary prevention includes the provision of information at a
population level to help individuals make informed choices about
their health-related behaviour and strategies to reduce the risk
factors associatedwith disease expression. Examples of population-
based primary prevention include:
• population-based health promotion programmes for
dependent older people;
• targeted health promotion programmes for individuals who
are cared for at home or in residential care;
• the use of professional staff to administer topical preventive
regimes, e.g. fluoride varnish;
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• the use of postal schemes to distribute high-dose fluoride
toothpaste to dependent older people (e.g. 5000 ppm or 2800
ppm).
Secondary prevention strategies include those population-based
programmes that detect early disease and intervene to prevent its
progression. Examples of population-based secondary prevention
programmes include:
• dentists screening for oral disease in dependent older
people;
• the use of non-dentist members of the dental team (e.g.
hygienists or hygiene therapists) to screen for oral disease in
dependent older people;
• non-dentally-trained care staff screening for oral disease in
dependent older people.
Tertiary prevention strategies include those that reduce morbidity
by restoring function and reducing disease-related complications.
Examples of population-based tertiary prevention programmes in-
clude:
• initiatives to improve the sign-posting of services for
dependent older people and their carers;
• access to services for dependent older people or people in
care homes (e.g. the use of mobile units to provide domiciliary
care in care homes) (e.g. http://www.gerodent.be).
We will exclude studies of interventions that are based on ’down-
stream’ individual clinical interventions rather than a population-
level approach to prevention.
Types of outcome measures
Primary outcomes
The primary outcome measure for the review is oral disease status.
This will include:
• pain;
• decayed, missing and filled teeth (e.g. DMFT, DMFS or
International Caries Detection and Assessment System);
• proportion of individuals with active coronal caries;
• proportion of individuals with active root caries;
• proportion of sites that bleed on probing.
Secondary outcomes
Where possible, we will collect other relevant outcome measures
including the following.
1. Other patient outcome measures, including:
• health status:
◦ physical health, e.g. reduced function (eating,
speaking);
◦ psychosocial outcomes, e.g. oral health related quality
of life (e.g. Oral Health Impact Profile);
• health behaviour:
◦ uptake and adherence to preventive interventions (e.g.
recruitment and retention rates);
◦ healthcare seeking behaviour as a result of the
intervention (e.g. improvements in access to care).
2. Quality of care, including:
• adherence to preventive strategies (primary, secondary and
tertiary) by dental professionals and formal and informal
caregivers.
3. Utilisation, coverage or access, including:
• utilisation of preventive strategies, e.g. uptake amongst care
homes, uptake amongst residents;
• coverage, e.g. number and type of dependent settings
utilising preventive strategies;
• access to services, e.g. availability of dental services, waiting
times to see dental professional.
4. Resource use, including:
• healthcare resources and costs, e.g. dental professional
resources and time, consumables and supplies of health
technologies;
• non-healthcare resources, e.g. transportation to healthcare
facilities;
• formal and informal caregiver time.
5. Healthcare provider outcomes, including:
• workload of dental professionals and formal and informal
caregivers;
• work morale of dental professionals and formal and
informal caregivers;
• stress, burnout, sick leave of both dental professionals and
formal and informal caregivers.
6. Social outcomes, including:
• empowerment, participation and networking of care homes;
• reduced isolation of informal caregivers at home;
• education of formal and informal caregivers.
7. Equity; in particular, inequalities in:
• oral and general health;
• utilisation, coverage or access;
• quality of care;
• resource use.
8. Adverse effects or harms (in particular):
• oral and general health (e.g. fluoride toxicity);
• utilisation, coverage or access;
• quality of care;
• resource use;
• healthcare providers;
• social outcomes.
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Search methods for identification of studies
Electronic searches
The Effective Practice and Organisaton of Care (EPOC) Informa-
tion Specialist will develop the final search strategy in consultation
with the authors. A preliminary draft of the MEDLINE strategy
is available in Appendix 1. We will adapt the MEDLINE strat-
egy for subscription databases and translate MeSH terms to the
controlled vocabularies of those databases as appropriate. We will
apply shorter, less complex strategies to open access databases and
search websites for grey literature because these search interfaces
do not usually support complex Boolean or other operators. We
will publish all search strategies used in the review. All databases
will be searched from inception to the date of search.
We will search the Cochrane Database of Systematic Reviews
(CDSR) and the Database of Abstracts of Reviews of Effects
(DARE) for related systematic reviews.
We will search the following databases (from inception) for pri-
mary studies:
• Cochrane Central Register of Controlled Trials
(CENTRAL), including the EPOC Group Specialised Register;
• MEDLINE, 1946 to present, In-Process and other non-
indexed citations, OvidSP;
• Embase, 1974 to present, OvidSP;
• CINAHL (Cumulative Index to Nursing and Allied Health
Literature), 1980 to present, EbscoHost;
• Science Citation Index and Social Sciences Citation Index,
1975 to present, ISI Web of Knowledge.
We will search the following trial registries:
• International Clinical Trials Registry Platform (ICTRP),
Word Health Organization (WHO) (www.who.int/ictrp/en/);
• ClinicalTrials.gov, US National Institutes of Health (NIH)
(clinicaltrials.gov/).
We will also conduct a grey literature search of the following re-
sources to identify studies not indexed in the databases listed above:
• OpenGrey (www.opengrey.eu/);
• Joanna Briggs Institute (www.joannabriggs.edu.au/
Search.aspx);
• National Institute for Health and Clinical Excellence
(NICE) (www.nice.org.uk/).
Searching other resources
We will review reference lists of all included studies and relevant
systematic reviews for additional potentially-eligible primary stud-
ies. We will also contact the authors of eligible studies and re-
searchers with expertise relevant to the review topic. We will also
conduct cited reference searches in ISI Citation indexes viaWeb of
Knowledge. All strategies used, including a list of sources screened
and relevant reviews/primary studies reviewed, will be provided in
appendices.
Data collection and analysis
Selection of studies
We will download all the titles and abstracts identified by the
electronic searches to a reference management database. We will
then remove duplicate entries and three of the review authors
(Paul Brocklehurst (PRB), Lynne Williams (LW) and Katarina
Jerkovi - osi (KJ)) will independently examine the remaining
references. We will exclude studies that do not meet the inclusion
criteria and obtain full-text copies of the identified references that
appear to meet the inclusion criteria. When there are insufficient
data in the study title or abstract to determine whether a study
fulfils the inclusion criteria, the same review authors will obtain
and assess the full report independently. Disagreement will be
resolved by discussion and, if needed, by an arbitrator. We will
record studies rejected at this and subsequent stages in the table
’Characteristics of excluded studies’.
We will include studies in the review irrespective of whether mea-
sured outcome data are reported in a ‘usable’ way. Studies that
meet the inclusion criteria will be included and described in the
’Characteristics of included studies’ table, even if they do not re-
port usable results.
We will document the selection process in sufficient detail to com-
plete a PRISMA flow chart (PRISMA 2016) and a table of ‘Char-
acteristics of excluded studies’.
Data extraction and management
We will extract data from included studies and assess their risk
of bias. Two review authors will extract data from each included
study independently and in duplicate using a tool developed for
the review.Wewill resolve differences by discussion and, if needed,
arbitration by a third person. If a single publication reports two or
more separate studies, then we will extract data from each study
separately. If the findings of a single study are spread across two
or more publications, then we will extract data from the publica-
tions as one. For each study with more than one control or com-
parison group for the intervention, we will extract the results for
each intervention arm. We will not double count data within a
meta-analysis and we will combine groups to create single pair-
wise comparisons as appropriate. For each trial we will record the
following data:
• year of publication, country of origin and source of study
funding;
• details of the participants, including demographic
characteristics and criteria for inclusion;
5Strategies to prevent oral disease in dependent older people (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
• details of the study design;
• details of the outcomes reported, including method of
assessment and adverse outcomes.
Assessment of risk of bias in included studies
Two review authors will independently assess risk of bias for each
study using the criteria outlined in the Cochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011) and the guidance
from the EPOC group (EPOC 2015). Any disagreement will be
resolved by discussion or by involving a third review author. We
will assess the risk of bias according to the following domains:
1. Random sequence generation;
2. Allocation concealment;
3. Blinding of participants and personnel;
4. Blinding of outcome assessment;
5. Incomplete outcome data;
6. Selective outcome reporting;
7. Baseline outcomes measurement;
8. Baseline characteristics;
9. Other bias.
For non-randomised studies we will use the criteria detailed in
Appendix 2.
We will judge each potential source of bias as high, low or unclear
risk, and provide a quote from the study report together with a
justification for our judgment in the ’Risk of bias’ table. We will
summarise the ’Risk of bias’ judgements across different studies
for each of the domains listed.
For each study, we will provide a summary assessment of overall
risk of bias:
• low risk when there is a low risk of bias across all key
domains;
• unclear risk of bias when there is an unclear risk of bias in
one or more of the key domains;
• high risk of bias when there is a high risk of bias in one or
more of the key domains.
We will consider blinding separately for different key outcomes
where necessary (e.g. for unblinded outcome assessment, risk of
bias for all-cause mortalitymay be very different than for a patient-
reported pain scale). Where information on risk of bias relates to
unpublished data or correspondence with a trialist, we will note
this in the ’Risk of bias’ table.
Measures of treatment effect
We will report outcomes for each study in natural units.
For dichotomous outcomes, if possible, the risk ratio (RR) from
statistical analyses adjusting for baseline differences (such as pois-
son regressions or logistic regressions) or the ratio of risk ratios (i.e.
the risk ratio post-intervention/risk ratio pre-intervention) will be
reported. We will not pool in one meta-analysis RRs that have
been adjusted for baseline differences and those that have not. For
continuous variables, if possible, the absolute change from a sta-
tistical analysis adjusting for baseline differences (such as regres-
sion models, mixed models or hierarchical models) or the relative
change adjusted for baseline differences in the outcome measures
(i.e. the absolute post-intervention difference between the inter-
vention and control groups - the absolute pre-intervention differ-
ence between the intervention and control groups)/the post-inter-
vention level in the control group) will be reported.
For ITS studies, we will use either a regression analysis with time
trends before and after the intervention (adjusted for auto-correla-
tion and any periodic changes) or ARIMA analysis. The results for
the outcomes will be presented as changes along two dimensions:
change in level and change in slope. Change in level is the imme-
diate effect of the intervention and is measured as the difference
between the fitted value for the first post-intervention data point
(one month after the intervention) minus the predicted outcome
one month after the intervention based on the pre-intervention
slope only. Change in slope is the change in the trend from pre- to
post-intervention, reflecting the long-term effect of the interven-
tion. As interpretation of the change in slope can be difficult, we
will present the long-term effects in a similar manner to the way
that immediate effects are presented.
If papers with ITS design do not provide an appropriate analysis
or reporting of results, but present the data points in a scannable
graph or in a table, the slope will be analysed using the methods
described in Ramsey 2003.
We will use summary tables to present the findings for the main
comparisons in the review, to interpret the results and draw con-
clusions about the effects of different interventions including the
size of effects and certainty of the evidence.
Unit of analysis issues
Should cluster randomised trials be included, we will undertake
analysis, whenever feasible, at the same level as the randomisation
or at the individual level, accounting for the clustering. The intra-
cluster correlation coefficient (ICC) of any included cluster RCTs
will be utilised to incorporate the design effect into the analysis.
If ICC is not apparent in the reports, estimation methods will
not be used. In this circumstance, we will not report the P values
or confidence intervals, as analyses not accounting for the design
effect have the potential to inflate the type 1 error rate and result
in artificially narrow confidence intervals.
Dealing with missing data
Where possible, we will contact the authors of included papers
if important data are not available. If we are not able to obtain
missing data, we will explicitly state this and report the results that
are available, provided they are not likely to be misleading (e.g. if
there is a unit of analysis error).
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Assessment of heterogeneity
Wewill assess the significance of any discrepancies in the estimates
of the treatment effects from the different studies by means of
Cochrane’s test for heterogeneity, where P < 0.1 will be consid-
ered significant (Higgins 2011). We will use the I2 statistic, which
describes the percentage total variation across studies that is due
to heterogeneity rather than chance, to quantify heterogeneity,
with an I2 statistic over 50% representing substantial heterogene-
ity (Higgins 2011).
Assessment of reporting biases
If there is a sufficient number of studies (more than 10) included
in any meta-analysis, we will assess publication bias according
to the recommendations on testing for funnel plot asymmetry
as described in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011).
Data synthesis
We will only undertake meta-analysis for clinically homogeneous
RCTs. We will undertake meta-analysis using a random-effects
model.Wewill combine risk ratios for dichotomous data andmean
differences for continuous data using a random-effects model, if
the data allow. Due to the expected diversity of the interventions
and outcomes, it may not be possible to pool the results. If com-
bining outcome data is not possible due to differences in the types
and reporting of outcomes then we will present a narrative sum-
mary, alongside a table of the standardised median effect size for
each outcome and the median effect sizes across studies for each
comparison. We will draw conclusions on the basis of method-
ological quality, transferability and results of the studies.
We will describe ongoing studies, where available, detailing the
primary author, research question(s), methods and outcome mea-
sures together with an estimate of the reporting date.
Subgroup analysis and investigation of heterogeneity
The review team accepts that subgroup comparisons are by their
nature observational and so subject to bias. If a small number
of studies is found, we will not undertake subgroup analyses or
random-effects modelling. Should sufficient studies warrant sub-
group analysis, this will be undertaken on the following basis:
• intervention type;
• setting (residential versus nursing care versus care at home)
- given the potential difference between staffing levels and formal
and informal caregivers;
• level of functional dependence - given the impact on uptake
and fidelity.
We will only undertake meta-analyses if there are studies of similar
comparisons reporting the same outcome measures. Should meta-
analysis be considered appropriate, these will be undertaken on
the basis of the subgroups identified above.
Sensitivity analysis
We will consider performing sensitivity analyses for missing data
by imputing a plausible range of data, and the potential impli-
cations of missing information will be discussed. In order to de-
termine how robust and consistent the results are, we will com-
pare RCTs deemed to be at low risk or bias to other studies. Any
methodological decisions taken in the course of preparing the re-
view will be checked for stability of results in a sensitivity analysis.
Summary of findings
We will summarise the findings of the main intervention compar-
ison for the most important outcomes by undertaking the follow-
ing procedure to create a ’Summary of Findings’ (SoF) table:
• listing the outcomes that we identify as the primary
outcome (health status and health behaviour);
• adding other important outcomes for which data are
reported, as appropriate (uptake amongst care homes, uptake
amongst residents, access to services and resource use and equity);
• adding other outcomes for which data are not reported, but
which would be important for policy-makers and stakeholders;
• assessing the certainty of the evidence for each outcome
using the GRADE approach (Appendix 3);
• summarising the findings for each outcome (quantitatively,
where possible);
• completing the SoF table;
• preparing bullet points that summarise the information in
the SoF table in plain language.
Two review authors will independently assess the certainty of
the evidence (high, moderate, low, and very low) using the
five GRADE considerations (study limitations, consistency of
effect, imprecision, indirectness and publication bias). We will
use methods and recommendations described in Section 8.5 and
Chapter 12 of the Cochrane Handbook (Higgins 2011) and the
EPOCworksheets (EPOC 2013), and using GRADEpro software
(GRADEpro GDT 2015). We will resolve disagreements on cer-
tainty ratings by discussion, provide justification for decisions to
down- or up-grade the ratings using footnotes in the table, and
make comments to aid readers’ understanding of the review where
necessary. We will use plain language statements to report these
findings.
A C K N OW L E D G E M E N T S
We thank the Cochrane Oral Health Group for their contribution
and support.
7Strategies to prevent oral disease in dependent older people (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
National Institute for Health Research, via Cochrane Infrastruc-
ture funding to the Effective Practice and Organisation of Care
Group (EPOC).The views andopinions expressed herein are those
of the authors and do not necessarily reflect those of the Systematic
Reviews Programme, NIHR, NHS or the Department of Health.
R E F E R E N C E S
Additional references
Albrecht 2013
Albrecht (nee Bunge) M, Kupfer R, Reissmann D, Haastert
B, Mühlhauser I, Köpke S. Oral health educational
interventions for nursing home staff and residents. Cochrane
Database of Systematic Reviews 2013, Issue 5. [DOI:
10.1002/14651858.CD010535]
Andersson 2007
Andersson K, Furhoff AK, Nordenram G, Wardh I. “Oral
health is not my department” - perceptions of older
patients’ oral health by general medical practitioners in
primary health care centres: a qualitative interview study.
Scandinavian Journal of Caring Sciences 2007;21(1):126–33.
Belsi 2013
Belsi A, Gonzalez-Maffe J, Jones K, Wright D, Gallagher
JE. Care home managers’ views of dental services for older
people living in nursing and residential homes in inner city
London. Community Dental Health 2013;30:77–82.
Bethel 2014
Bethel LA, Kim EE, Seitz CM, Swann BJ. Innovations in
dental care delivery for the older adult. Dental Clinics of
North America 2014;58:845-55.
Bots-VantSpijker 2014
Bots-VantSpijker PC, Vanobbergen JN, Schols JM,
Schaub RM, Bots CP, de Baat C. Barriers of delivering
oral health care to older people experienced by dentists: a
systematic literature review. Community Dentistry and Oral
Epidemiology 2014;42(2):113–21.
Branca 2009
Branca S, Bennati E, Ferlito L, Spallina G, Cardillo E,
Malaguarnera M, et al. The health-care in the extreme
longevity. Archives of Gerontology and Geriatrics 2009;49(1):
32-4.
Brocklehurst 2015
Brocklehurst PR, Mackay L, Goldthorpe J, Pretty IA. Older
people and oral health: setting a patient-centred research
agenda. Gerodontology 2015 May 23 [Epub ahead of
print]. [DOI: 10.1111/ger.12199]
Coleman 2002
Coleman P. Improving oral health care for the frail elderly: a
review of widespread problems and best practices. Geriatric
Nursing 2002;23:189–99.
De Visschere 2006
De Visschere LM, Grooten L, Theuniers G, Vanobbergen
JN. Oral hygiene of elderly people in long-term care
institutions - a cross-sectional study. Gerodontology 2006;23
(4):195-204.
De Visschere 2015a
De Visschere L, de Baat C, De Meyer L, van der Putten GJ,
Peeters B, Söderfelt B, et al. The integration of oral health
care into day-to-day care in nursing homes: a qualitative
study. Gerodontology 2015;32(2):115–22.
De Visschere 2015b
De Visschere L, Janssens B, De Reu G, Duyck J,
Vanobbergen J. An oral health survey of vulnerable
older people in Belgium. Clinical Oral Investigations
2015 Nov 14 [Epub ahead of print]. [DOI: 10.1007/
s00784-015-1652-8]
Derks 2015
Derks J, Tomasi C. Peri-implant health and disease. Journal
of Clinical Periodontology 2015;42(Suppl)(16):S158- S171.
EPOC 2013
Cochrane Effective Practice and Organisation of Care
Group. EPOC Worksheets for preparing a Summary of
Findings (SoF) table using GRADE. EPOC Resources for
review authors. Oslo: Norwegian Knowledge Centre for the
Health Services, epoc.cochrane.org/epoc-specific-resources-
review-authors 2013 (accessed prior to 16 September 2016).
EPOC 2015
Cochrane Effective Practice and Organisation of Care
Group. Suggested risk of bias criteria for EPOC
reviews. EPOC Resources for review authors. Oslo:
Norwegian Knowledge Centre for the Health Services.
epoc.cochrane.org/epoc-specific-resources-review-authors
2015 (accessed prior to 16 September 2016).
Everaars 2015
Everaars B, Jerkovi - osi K, van der Putten G-J, van der
Heijden GJMG. Probing problems and priorities in oral
health (care) among community dwelling elderly in the
Netherlands - a mixed method study. International Journal
of Health Sciences Research 2015;5(9):415–29.
FDI 2016
FDI/World Dental Federation. Shaping the future of oral
health. www.fdiworldental.org/oral-health/vision-2020/
shaping-the-future-of-oral-health.aspx (accessed prior to 16
September 2016).
Featherstone 1988
Featherstone JDB, Ten Cate JM. Physicochemical aspects
of fluoride-enamel interactions. In: Ekstrand J, Fejerskov
O, Silverstone LM editor(s). Fluoride in Dentistry.
Copenhagen: Munksgaard, 1988:125–49.
8Strategies to prevent oral disease in dependent older people (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ford 2010
Ford PJ, Raphael SL, Cullinan MP, Jenkins AJ, West MJ,
Seymour GJ. Why should a doctor be interested in oral
disease?. Expert Review of Cardiovascular Therapy 2010;8:
1483–93.
Frenkel 2002
Frenkel H, Harvey I, Needs K. Oral health care education
and its effect on caregivers’ knowledge and attitudes: a
randomised controlled trial. Community Dentistry and Oral
Epidemiology 2002;30(2):91-100.
Gerritsen 2010
Gerritsen AE, Allen PF, Witter DJ, Bronkhorst EM,
Creugers NH. Tooth loss and oral health-related quality
of life: a systematic review and meta-analysis. Health and
Quality of Life Outcomes 2010;8(126):1–13.
Gibson 2011
Gibson G, Jurasic MM, Wehler CJ, Jones JA. Supplemental
fluoride use for moderate and high caries risk adults: a
systematic review. Journal of Public Health Dentistry 2011;
71(3):171-84.
Gluhak 2010
Gluhak C, Arnetzl GV, Kirmeier R, Jakse N, Arnetzl G.
Oral status among seniors in nine nursing homes in Styria,
Austria. Gerodontology 2010;27(1):47-52.
GRADEpro GDT 2015 [Computer program]
GRADE Working Group, McMaster University.
GRADEpro Guidance Development Tool. gradepro.org.
Version (accessed prior to 16 September 2016). Hamilton
(ON): GRADE Working Group, McMaster University,
2015.
Heath 1999
Heath MR, Müller F, Lewis D, McKerlie R. Clinical
progress: standards of dental care in residential homes: a
web way forward. Gerodontology 1999;16:123–5.
Higgins 2011
Higgins JPT, Green S (editors). Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0
[updated March 2011]. The Cochrane Collaboration,
2011. Available from www.cochrane-handbook.org.
Hopcraft 2012
Hopcraft MS, Morgan MV, Satur JG, Wright FA.
Edentulism and dental caries in Victorian nursing homes.
Gerodontology 2012;29(2):512-9.
Jablonski 2009
Jablonski RA, Swecker T, Munro C, Grap MJ, Ligon M.
Measuring the oral health of nursing home elders. Clinical
Nursing Research 2009;18(3):200–5.
Janssens 2016
Janssens B, De Visschere L, van der Putten GJ, de Lugt-
Lustig K, Schols JM, Vanobbergen J. Effect of an oral
healthcare protocol in nursing homes on care staffs’
knowledge and attitude towards oral health care: a cluster-
randomised controlled trial. Gerodontology 2016 Nov 26
[Epub ahead of print]. [DOI: 10.1111/ger.12164]
Kandelman 2008
Kandelman D, Petersen PE, Ueda H. Oral health, general
health, and quality of life in older people. Special Care
Dentistry 2008;28:224–36.
Karki 2015
Karki AJ, Monaghan N, Morgan M. Oral health status of
older people living in care homes in Wales. British Dental
Journal 2015;219(7):331–4.
Kingston 2012
Kingston A, Collerton J, Davies K, Bond J, Robinson L,
Jagger C. Losing the ability in activities of daily living in the
oldest old: a hierarchic disability scale from the Newcastle
85+ study. PLoS ONE 2012;7(2):e31665. [DOI: http://
dx.doi.org/10.1371/journal.pone.0031665]
Listl 2010
Listl S. Income-related inequalities in dental service
utilization by Europeans aged 50+. Journal of Dental
Research 20101;90(6):717–23. [DOI: 10.1177/
0022034511399907]
MacEntee 2000
MacEntee MI. Oral care for successful aging in long-term
care. Journal of Public Health Dentistry 2000;60(4):326–9.
MacEntee 2007
MacEntee MI, Wyatt CC, Beattie BL, Paterson B, Levy-
Milne R, McCandless L, et al. Provision of mouth-care in
long-term care facilities: an educational trial. Community
Dentistry and Oral Epidemiology 2007;35(1):25-34.
Maurinho 2013
Marinho VCC, Worthington HV, Walsh T, Clarkson
JE. Fluoride varnishes for preventing dental caries
in children and adolescents. Cochrane Database of
Systematic Reviews 2013, Issue 7. [DOI: 10.1002/
14651858.CD002279.pub2]
Morgan 2015
Morgan MZ, Johnson IG, Hitchings E, Monaghan
NP, Karki AJ. Dentist skill and setting to address
dental treatment needs of care home residents in Wales.
Gerodontology 2015 Feb 3 [Epub ahead of print].
Moynihan 2007
Moynihan PJ. The relationship between nutrition and
systemic and oral well-being in older people. Journal of the
American Dental Association 2007;138:493–7.
Murray 1991
Murray JJ, Rugg-Gunn AJ, Jenkins GN. Fluorides in Caries
Prevention. Oxford: Wright, 1991.
Nitschke 2004
Nitschke I, Muller F. The impact of oral health on the
quality of life in the elderly. Oral Health & Preventive
Dentistry 2004;2:271–5.
Nitschke 2005
Nitschke I, Ilgner A, Müller F. Barriers to provision of
dental care in long-term care facilities: the confrontation
with ageing and death. Gerodontology 2005;22:123–9.
9Strategies to prevent oral disease in dependent older people (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Nowjack-Raymer 2003
Nowjack-Raymer RE, Sheiham A. Association of edentulism
and diet and nutrition in US adults. Journal of Dental
Research 2003;82:123–6.
Paulsson 2002
Paulsson G, Söderfeldt B, Nederfors T, Fridlund B. Nursing
personnels’ views on oral health from a health promotion
perspective: a grounded theory analysis. Acta Odontologica
Scandinavica 2002;60:42–9.
Platform for Better Oral Health in Europe 2015
Platform for Better Oral Health in Europe. Targets for
2020. www.oralhealthplatform.eu/our-work/targets-for-
2020/ (accessed prior to 17 September 2016).
Porter 2015
Porter J, Ntouva A, Read A, Murdoch M, Ola D, Tsakos G.
Impact of oral health on the quality of life of nursing home
residents. Health and Quality of Life Outcomes 2015;13:102.
Pretty 2014a
Pretty IA. The life course, care pathways and elements of
vulnerability. A picture of health needs in a vulnerable
population. Gerodontology 2014;31 (Suppl. 1):1-8.
Pretty 2014b
Pretty IA, Ellwood RP, Lo ECM, MacEntee MI, Muller F,
Rooney E, et al. The Seattle Care Pathway for securing oral
health in older patients. Gerodontology 2014;31 (Suppl. 1):
77-87.
PRISMA 2016
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses. prisma-statement.org (accessed prior to 17
September 2016).
Ramsey 2003
Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas
RE. Interrupted time series design in health technology
assessment: lessons from two systematic reviews of behavior
change strategies. International Journal of Technology
Assessment in Health Care 2003;19(4):612–23.
Riley 2013
Riley P, Lamont T. Triclosan/copolymer containing
toothpastes for oral health. Cochrane Database of
Systematic Reviews 2013, Issue 12. [DOI: 10.1002/
14651858.CD010514.pub2]
Rouxel 2016
Rouxel P, Tsakos G, Chandola T, Watt RG. Oral health:
a neglected aspect of subjective well-being in later life.
Journals of Gerontology Series B Psychological Sciences and
Social Science 2016 Mar 12 [Epub ahead of print]. [DOI:
10.1093/geronb/gbw024]
Samson 2008
Samson H, Strand GV, Haugejorden O. Change in oral
health status among institutionalized Norwegian elderly
over a period of 16 years. Acta Odontologica Scandinavica
2008;66(6):368-73.
Steele 2004
Steele JG, Sanders AE, Slade GD, Allen PF, Lahti S, Nuttall
N. How do age and tooth loss affect oral health impacts and
quality of life? A study comparing two national samples.
Community Dentistry and Oral Epidemiology 2004;32:
107–14.
Steele 2009
Steele J. Adult Dental Health Survey. http://
content.digital.nhs.uk/pubs/dentalsurveyfullreport09 2009.
Tan 2010
Tan HP, Lo ECM, Dyson JE, Luo Y, Corbet EF. A
randomized trial on root caries prevention in elders. Journal
of Dental Research 2010;89(10):1086–90.
Thomson 2012
Thomson WM. Social inequality in oral health. Community
Dentistry and Oral Epidemiology 2012;40 Suppl 2:28-32.
Thomson 2014
Thomson M. Epidemiology of oral health conditions in
older people. Gerodontology 2014;31 (Suppl. 1):9-16.
Touger-Decker 2007
Touger-Decker R, Mobley CC. Position of the American
Dietetic Association: oral health and nutrition. Journal of
the American Dietary Association 2007;107:1418–28.
Tsakos 2011
Tsakos G, Demakakos P, Breeze E, Watt RG. Social
gradients in oral health in older adults: findings from the
English longitudinal survey of aging. American Journal of
Public Health 2011;101(10):1892-9.
van der Putten 2014
van der Putten G-J, de Baat C, Visschere L, Schols J. The
challenge of setting - from community to residential care.
Gerodontology 2014;31 (Suppl. 1):17-24.
Vanobbergen 2005
Vanobbergen JN, De Visschere LM. Factors contributing to
the variation in oral hygiene practices and facilities in long-
term care institutions for the elderly. Community Dental
Health 2005;22(4):260–5.
Walls 2004
Walls AW, Steele JG. The relationship between oral health
and nutrition in older people. Mechanisms of Ageing and
Development 2004;125:853–7.
Walls 2012
Walls AW, Meurman JH. Approaches to caries prevention
and therapy in the elderly. Advances in Dental Research
2012;24(2):36-40.
Walls 2014
Walls A. Challenges of the dentate. Gerodontology 2014;31
(Suppl. 1):25-30.
Wardh 2013
Wårdh I, Jonsson M, Wikström M. Attitudes to and
knowledge about oral health care among nursing home
personnel - an area in need of improvement. Gerodontology
2012;29(2):787-92.
WHO 2008
Kanström L, Zamaro G, Sjöstedt C, Green G (eds).
Healthy ageing profiles: guidance for producing local
health profiles of older people. World Health Organisation,
10Strategies to prevent oral disease in dependent older people (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
www.euro.who.int/en/publications/abstracts/healthy-
ageing-profiles.-guidance-for-producing-local-health-
profiles-for-older-people 2008 (accessed 17 September
2016).
WHO 2011
World Health Organisation. Global health and aging.
www.who.int/ageing/publications/global_health/en/ 2011
(accessed 17 September 2016). [ NIH Publication no.
11–7737]
WHO 2012
World Health Organisation. Policies and priority
interventions for healthy aging. www.euro.who.int/en/
health-topics/Life-stages/healthy-ageing/publications/
2012/policies-and-priority-interventions-for-healthy-ageing
2012.
Widstrom 2004
Widstrom E, Eaton KA. Oral healthcare systems in the
extended European union. Oral Health and Preventive
Dentistry 2004;2:155–94.
Wilson 1968
Wilson JM, Jungner YG. Principles and Practice of Screening
for Disease. Geneva: World Health Organisation, 1968.
[Public Health Papers No. 34]
Wong 2011
Wong MC, Clarkson J, Glenny AM, Lo EC, Marinho VC,
Tsang BW, et al. Cochrane reviews on the benefits/risks of
fluoride toothpastes. Journal of Dental Research 2011;90(5):
573-9.
∗ Indicates the major publication for the study
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1946 to Present
No. Search terms
1 exp tooth diseases/pc
2 exp mouth diseases/pc
3 halitosis/pc
4 oral health/
5 ((dental or tooth or teeth or enamel or root*) and (decay* or caries or carious or white spot* or plaque or reminerali* or
deminerali* or erosion* or abrasion* or wear)).ti,ab
6 (denture* and (clean* or clens*)).ti,ab.
7 (periodont* or gingivi* or gingiva*).ti,ab.
8 (stomatitis or mouth ulcer* or oral ulcer* or (oral adj3 candidi*) or (mouth* adj3 candidi*) or aphthous ulcer* or (aphthae
adj3 ulcer*) or (mucositis adj3 mouth*) or (mucositis adj3 oral) or xerostomi* or dry mouth*).ti,ab
9 ((oral adj3 health*) or (mouth adj3 health*) or (dental adj3 health*)).ti,ab
10 leukoplak*.ti,ab.
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(Continued)
11 hairy tongue*.ti,ab.
12 (halitosis or mouth odour* or mouth odor* or mouth malodour* or mouth malodor* or oral malodour* or oral malodor* or
(breath adj5 malodour*) or (breath adj5 malodor*) or (breath adj5 odour*) or (breath adj5 odor*)).ti,ab
13 or/4-12
14 or/1-3
15 aged/
16 “aged, 80 and over”/
17 frail elderly/
18 (geriatric? or senior? or elderly).ti,ab.
19 (old* adult? or old* person? or old* people or old* patient?).ti,ab
20 geriatrics/
21 “health services for the aged”/
22 geriatric dentistry/
23 or/15-22
24 prevent*.ti,ab.
25 exp preventive dentistry/
26 exp cariostatic agents/
27 (fluoride? or fluoridation).ti,ab.
28 exp dentifrices/
29 exp mouthwashes/
30 exp oral hygiene/
31 (oral adj4 care).ti,ab.
32 (oral hygiene or mouth* care or dental care or (care adj3 teeth) or (mouth* adj3 hygiene) or (plaque adj3 control*) or (plaque
adj3 remov*)).ti,ab
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(Continued)
33 (toothbrush* or tooth-brush* or toothpaste* or dentifrice* or mouthwash* or mouth-wash* or mouthrinse* or mouth-rinse*)
.ti,ab
34 (floss* or interdental brush* or inter-dental brush* or (tooth adj2 clean*) or (teeth adj2 clean*) or (denture* adj2 hygien*) or
(denture* adj2 clean*) or (tongue* adj2 scrap*) or (tongue* adj2 brush*) or (chewing adj2 stick*) or (chewing adj2 gum*)).ti,
ab
35 health education, dental/
36 exp health promotion/
37 mass screening/
38 screen*.ti,ab.
39 ((dental or dentist? or oral* or mouth or gum? or tooth or teeth) adj5 (instruct* or advise* or advice or educat* or promot* or
teach* or train*)).ti,ab
40 or/24-39
41 or/25-39
42 13 and 40 and 23
43 14 and 41 and 23
44 or/42-43
45 randomized controlled trial.pt.
46 controlled clinical trial.pt.
47 multicenter study.pt.
48 pragmatic clinical trial.pt.
49 (randomis* or randomiz* or randomly).ti,ab.
50 groups.ab.
51 (trial or multicenter or multi center or multicentre or multi centre).ti
52 (intervention? or effect? or impact? or controlled or control group? or (before adj5 after) or (pre adj5 post) or ((pretest or pre
test) and (posttest or post test)) or quasiexperiment* or quasi experiment* or pseudo experiment* or pseudoexperiment* or
evaluat* or time series or time point? or repeated measur*).ti,ab
53 non-randomized controlled trials as topic/
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(Continued)
54 interrupted time series analysis/
55 controlled before-after studies/
56 or/45-55
57 exp animals/
58 humans/
59 57 not (57 and 58)
60 review.pt.
61 meta analysis.pt.
62 news.pt.
63 comment.pt.
64 editorial.pt.
65 cochrane database of systematic reviews.jn.
66 comment on.cm.
67 (systematic review or literature review).ti.
68 or/59-67
69 56 not 68
70 44 and 69
Appendix 2. Risk of bias for non-randomised studies
Non-randomised controlled trials (NRCTs) and controlled before-after (CBA) studies will be judged according to the following criteria
(EPOC 2015; Higgins 2011):
1. Was the allocation sequence adequately generated? “Low risk” will be scored if a random component in the sequence
generation process is described. “High risk” will be scored if a non-random method is used. NRCTs and CBA studies will be scored
“High risk”. “Unclear risk” will be scored if the allocation sequence method is not specified in the paper.
2. Was the allocation concealed? “Low risk” will be scored if the unit of allocation was by institution, team or professional and
allocation was performed on all units at the start of the study; or if the unit of allocation was by patient or episode of care and there
was some form of centralised randomisation scheme, an on-site computer system or sealed opaque envelopes were used. CBA studies
will be scored “High risk”. “Unclear risk” will be scored if allocation concealment is not specified in the paper.
3. Were baseline outcome measurements similar? “Low risk” will be scored if performance or patient outcomes were measured
prior to the intervention, and no important differences were present across study groups. In RCTs, “Low risk” will be scored if
imbalanced but appropriate adjusted analysis was performed (e.g. analysis of covariance). “High risk” will be scored if important
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differences were present and not adjusted for in analysis. “Unlcear risk” will be scored if there were no baseline measure of outcome in
an RCT.
4. Were baseline characteristics similar? “Low risk” will be scored if baseline characteristics of the study and control providers are
reported and similar. “Unclear risk” will be used if it is not clear in the paper (e.g. no data are presented). “High risk” will be scored if
there is no report of characteristics in text or tables or if there are differences between control and intervention providers.
5. Were incomplete outcome data adequately addressed? “Low risk” will be scored if missing outcome measures were unlikely to
bias the results. “High risk” will be scored if missing outcome data were likely to bias the results. “Unclear risk” will be scored if this is
not specified in the paper (we will not assume 100% follow up unless stated explicitly).
6. Was knowledge of the allocated interventions adequately prevented during the study? “Low risk” will be scored if the
authors state explicitly that the primary outcome variables were assessed blindly, or the outcomes are objective. Primary outcomes are
those variables that correspond to the primary hypothesis or question as defined by the authors. “High risk” will be scored if the
outcomes were not assessed blindly. “Unclear risk” will be scored if this is not specified in the paper.
7. Was the study adequately protected against contamination? “Low risk” will be scored if allocation was by community,
institution or practice and it is unlikely that the control group received the intervention. “High risk” will be scored if it is likely that
the control group received the intervention. “Unclear risk” will be scored if professionals were allocated within a clinic or practice and
it is possible that communication between intervention and control professionals could have occurred.
8. Was the study free from selective outcome reporting? “Low risk” will be scored if there is no evidence that outcomes were
selectively reported. “High risk” will be scored if some important outcomes are subsequently omitted from the results. “Unclear risk”
will be scored if this is not specified in the paper.
9. Was the study free from other risks of bias? “Low risk” will be scored if there is no evidence of other risk of biases.
Based on the recommendations of EPOC (EPOC 2015), we will assess the risk of bias of interrupted time series (ITS) studies according
to the following domains:
1. Was the intervention independent of other changes? “Low risk” will be scored if there are compelling arguments that the
intervention occurred independently of other changes over time and the outcome was not influenced by other confounding variables/
historic events during the study period. If events/variables are identified, we will note what they are. “High risk” will be scored if it is
reported that the intervention was not independent of other changes in time.
2. Was the shape of the intervention effect prespecified? “Low risk” will be scored if the point of analysis is the point of
intervention, or a rational explanation for the shape of intervention effect was given by the author(s). Where appropriate, this should
include an explanation if the point of analysis is not the point of intervention. “High risk” will be scored if it is clear that the
condition above criterion is not met.
3. Was the intervention unlikely to affect data collection? “Low risk” will be scored if it is reported that intervention itself was
unlikely to affect data collection (for example, sources and methods of data collection were the same before and after the
intervention). “High risk” will be scored if the intervention itself was likely to affect data collection (for example, any change in source
or method of data collection reported).
4. Was knowledge of the allocated interventions adequately prevented during the study? “Low risk” will be scored if the
authors state explicitly that the primary outcome variables were assessed blindly, or the outcomes are objective, e.g. length of hospital
stay. Primary outcomes are those variables that correspond to the primary hypothesis or question as defined by the authors. “High
risk” will be scored if the outcomes were not assessed blindly. “Unclear risk” will be scored if this is not specified in the paper.
5. Were incomplete outcome data adequately addressed? “Low risk” will be scored if missing outcome measures were unlikely to
bias the results (e.g. the proportion of missing data was similar in the pre- and post-intervention periods or the proportion of missing
data was less than the effect size, i.e. unlikely to overturn the study result). “High risk” will be scored if missing outcome data were
likely to bias the results. “Unclear risk” will be scored if this is not specified in the paper (we will not assume 100% follow up unless
stated explicitly).
6. Was the study free from selective outcome reporting? “Low risk” will be scored if there is no evidence that outcomes were
selectively reported (e.g. all relevant outcomes in the methods section are reported in the results section). “High risk” will be scored if
some important outcomes are subsequently omitted from the results. “Unclear risk” will be scored if this is not specified in the paper.
7. Was the study free from other risks of bias? “Low risk” will be scored if there is no evidence of other risk of biases. If the ITS
study has ignored secular (trend) changes and performed a simple t-test of the pre- versus post-intervention periods without further
justification, we will exclude the study from the review unless re-analysis is possible.
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Appendix 3. ’Summary of Findings’ and GRADE
Patients or population:
Settings:
Intervention:
Comparison:
Outcome Impact Number of participants Quality of the evidence (GRADE)
C O N T R I B U T I O N S O F A U T H O R S
Development of the protocol based on the latest Cochrane guidance: PRB
Identification of studies: PRB, LW, KJ
Assessment of risk of bias: PRB, LW, ZH, KJ, Martina Hayes (MH)
Data input/synthesis: PRB, LW, ZH
Discussion and recommendations for practice: PRB, LW, KJ, MH, Richard G Watt (RGW), George Tsakos (GT), Gerry McKenna
(GMc), Ivor Chestnutt (IC), Iain Pretty (IAP), Christopher Burton.
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